What We're Reading: Page 241
Industry reads hand-picked by our editors
Mar 05, 2019
-
The New York Times
H.I.V. Is Reported Cured in a Second Patient, a Milestone in the Global AIDS Epidemic
-
Kaiser Health News
Big Pharma Gave Money To Patient Advocacy Groups Opposing Medicare Changes
-
Reuters
OxyContin maker Purdue Pharma exploring bankruptcy - sources
-
The Wall Street Journal
Celgene Odds Are in Investors' Favor
Mar 04, 2019
-
The New York Times
Drug Companies and Doctors Battle Over the Future of Fecal Transplants
-
Healthcare Dive
Mixing medicine and money: Why the rise of health system VCs is raising ethical concerns
-
The Economist
'Repurposing' off-patent drugs offers big hopes of new treatments
-
The Wall Street Journal
The Side Effects of Million-Dollar Drugs
Mar 01, 2019
-
The New York Times
Big pharma's hunt for new drugs is pushing up cost of deals
-
Axios
Pharma's research budgets are usually bigger than its profits
-
CNN
Newly discovered Alzheimer's genes further hope for future treatments
-
Endpoints
Pfizer’s blockbuster safety issue jumps the Atlantic as EMA launches its own review of Xeljanz
-
Kaiser Health News
Americans ready to crack down on drug prices that force some to skip doses
Feb 28, 2019
Feb 27, 2019
-
Evaluate
Adcom gives Karyopharm a second chance with selinexor
-
Reuters
Germany's Merck makes $5.9 billion counterbid for Versum
-
San Francisco Business Times
Big Pharma trims projects — and a potential $1 billion in payments — from collaboration with small Peninsula biotech
-
Kaiser Health News
Meow-ch! The $48,512 cat bite
Feb 26, 2019
Feb 25, 2019
-
The New York Times
It's Time for Pharmaceutical Companies to Have Their Tobacco Moment
-
The Washington Post
Her biotech firm solves medical mysteries. (And no, it’s not Theranos.)
-
Reuters
Sinovac Biotech activates 'poison pill' defense in rare move
-
Bloomberg
How Pharma Lost Its Edge in Washington
Previous
